Prospective Observational Non-Interventional Study of Correlation of Treatment With Androcur, Disease Stage, Testosterone Level, Age With Sexual Function and Erectile Dysfunction (Measured by IIEF-5 Validated Questionnaire).
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2012
At a glance
- Drugs Cyproterone (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms ANES
- Sponsors Bayer
- 10 Jun 2017 Biomarkers information updated
- 10 Nov 2011 Planned end date changed from 1 Sep 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 10 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.